IVERIC bio, Inc. Deferred Tax Assets, Valuation Allowance
IVERIC bio, Inc. had Deferred Tax Assets, Valuation Allowance of $269.20 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2023-03-01
- 2022-12-31: Deferred Tax Assets, Valuation Allowance $269.20M.
- 2021-12-31: Deferred Tax Assets, Valuation Allowance $206.47M.
- 2020-12-31: Deferred Tax Assets, Valuation Allowance $171.67M.
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $142.32M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $269.20M 10-K · filed 2023-03-01 | |
| 2021-12-31 | $206.47M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $171.67M 10-K · filed 2022-02-24 | |
| 2019-12-31 | $142.32M 10-K · filed 2021-03-04 | |
| 2018-12-31 | $122.61M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $147.57M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $233.59M 10-K · filed 2018-03-05 | |
| 2015-12-31 | $171.97M 10-K · filed 2017-02-28 | |
| 2014-12-31 | $136.14M 10-K · filed 2016-02-26 | $117.55M 10-K · filed 2015-03-02 |
| 2013-12-31 | $64.02M 10-K/A · filed 2015-07-28 | $47.35M 10-K · filed 2014-03-11 |
| 2012-12-31 | $42.66M 10-K · filed 2014-03-11 |